The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year. The highly anticipated Adept-2 study will not read out by the year’s end as previously planned after BMS identified “ …

Donald Trump has found himself at the centre of yet another media storm, with fresh accusations that the president struggled to stay awake during a high-profile cabinet meeting on Dec. 2. These new claims have done little to quell the swirling Donald Trump …

When we think of cognitive decline and progressive brain disorders, we tend to think of conditions like Alzheimer’s disease, dementia, etc, and we frequently club them together in the same bracket as if both those conditions were synonymous with each other …

Researchers at Rutgers University–Newark and community outreach workers are exploring new ways to engage men—especially Black men—in Alzheimer’s disease research, according to a university news release.   Alzheimer’s is a progressive illness affecting …

Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression speed of Alzheimer's disease. Photo by Adobe Stock/HealthDay News Obesity might contribute to faster progression of Alzheimer…

At the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) Conference, held December 1-5 in San Diego, California, a poster presentation highlighted the rationale and design of a phase 2 study (NCT07094516) testing the effects of investigational VHB937 ( …

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, according to a new study being …

Alzheimer's disease (AD) is a neurodegenerative condition characterized by the progressive deterioration of brain cells, which prompts memory loss, a decline in mental functions and behavioral changes. Estimates suggest that this disease affects …

The small molecule spermine has the potential to stop the toxic build-up of proteins in the brain that characterizes diseases like Alzheimer's and Parkinson's, researchers have found – and it works a bit like melting cheese on spaghetti. We've …

Newswise — SAN DIEGO, Dec. 1, 2025 -- Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15 million Series A financing round. The …